MediPharm Labs Corp. (TSX:LABS)

Canada flag Canada · Delayed Price · Currency is CAD
0.0650
-0.0050 (-7.14%)
At close: Mar 6, 2026
-13.33%
Market Cap 27.62M
Revenue (ttm) 46.10M
Net Income (ttm) -8.03M
Shares Out 424.86M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 138,610
Average Volume 108,328
Open 0.0700
Previous Close 0.0700
Day's Range 0.0650 - 0.0700
52-Week Range 0.0600 - 0.1200
Beta 0.92
RSI 44.14
Earnings Date Mar 27, 2026

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll canna... [Read more]

Sector Healthcare
Founded 2015
Employees 161
Stock Exchange Toronto Stock Exchange
Ticker Symbol LABS
Full Company Profile

Financial Performance

In 2024, MediPharm Labs's revenue was 41.96 million, an increase of 26.92% compared to the previous year's 33.06 million. Losses were -10.69 million, -18.26% less than in 2023.

Financial Statements

News

There is no news available yet.